Related Experiment Video

Updated: Oct 4, 2025

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

940

Pediatric Restrictive Cardiomyopathies

Raffaello Ditaranto1, Angelo Giuseppe Caponetti1, Valentina Ferrara1

  • 1Cardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, IRCCS, Sant'Orsola Hospital, University of Bologna, Bologna, Italy.

Frontiers in Pediatrics
|February 11, 2022
PubMed

Insights

Pediatric restrictive cardiomyopathy (RCM) is rare but serious, often leading to pulmonary hypertension and sudden death. Heart transplantation is the primary treatment for this challenging pediatric heart condition.

Area of Science:

  • Pediatric cardiology
  • Cardiovascular research
  • Rare pediatric diseases

Background:

  • Restrictive cardiomyopathy (RCM) is the least common pediatric heart muscle disease, affecting 2.5-3% of children.
  • Pediatric RCM is associated with poor prognosis, including pulmonary hypertension, thromboembolic events, and sudden death.
  • Medical and surgical treatments are limited, making heart transplantation the main therapeutic option.

Purpose of the Study:

  • To review the causes, clinical presentation, diagnostic evaluation, treatment, and prognosis of pediatric restrictive cardiomyopathy.
  • To provide a comprehensive overview of this rare but severe pediatric heart condition.

Main Methods:

  • Literature review of pediatric restrictive cardiomyopathy.
  • Synthesis of information on etiology, clinical features, diagnosis, treatment, and outcomes.

Main Results:

  • RCM presents with severe diastolic dysfunction and restrictive ventricular filling, normal ejection fraction, and normal wall thickness.
  • Etiologies are diverse, including genetic/familial and acquired causes, each with unique pathophysiology.
  • High mortality rates and limited treatment options underscore the need for specialized management.

Conclusions:

  • Pediatric RCM requires a thorough understanding of its varied causes and clinical manifestations.
  • Effective management strategies and timely interventions, including heart transplantation, are crucial for improving outcomes.
  • Further research into the pathophysiology and treatment of pediatric RCM is warranted.

Keywords:
cardiomyopathyheart transplant (HTx)pediatric cardiomyopathiesrestrictive cardiomyopathy (RCM)sarcomeric cardiomyopathy

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K
Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.4K

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
77
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
101
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
50
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
56
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
65